← Research lines
L9

NAD+ and ovarian function

The 2025-2026 frontier. NAD+ decline, SIRT1/SIRT3/SIRT6, NMN vs NR, and mitochondrial quality in oocytes.

StatusCompleted
PriorityHigh
Progress6/6 subtopics
Depends onL4, L5

Subtopics

  1. 9.1
    NAD+ decline and ovarian aging
    Completed 2026-09-08 · View report →
  2. 9.2
    SIRT6 and DNA repair in oocytes
    Completed 2026-09-10 · View report →
  3. 9.3
    NMN vs NR: bioavailability and clinical evidence
    Completed 2026-09-12 · View report →
  4. 9.4
    CD38 as an NAD+ siphon
    Completed Wed Sep 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · View report →
  5. 9.5
    NAD+ and mitochondria in granulosa cells
    Completed Sat Sep 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · View report →
  6. 9.6
    NAD+ precursors in foods vs supplements
    Completed Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · View report →

Published reports